267 related articles for article (PubMed ID: 6127132)
1. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
Finberg JP; Tenne M
Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132
[TBL] [Abstract][Full Text] [Related]
2. Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.
Finberg JP; Tenne M; Youdim MB
Br J Pharmacol; 1981 May; 73(1):65-74. PubMed ID: 6793119
[TBL] [Abstract][Full Text] [Related]
3. Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats.
Finberg JP; Tal A
Br J Pharmacol; 1985 Mar; 84(3):609-17. PubMed ID: 2985158
[TBL] [Abstract][Full Text] [Related]
4. Examination of the paradoxical lack of responsiveness of the guinea-pig vas deferens to tyramine.
Rand MJ; Story DF; Dowding T
J Auton Pharmacol; 1989 Oct; 9(5):315-28. PubMed ID: 2613734
[TBL] [Abstract][Full Text] [Related]
5. Deamination of hordenine by monoamine oxidase and its action on vasa deferentia of the rat.
Barwell CJ; Basma AN; Lafi MA; Leake LD
J Pharm Pharmacol; 1989 Jun; 41(6):421-3. PubMed ID: 2570842
[TBL] [Abstract][Full Text] [Related]
6. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
Celuch SM; Juorio AV
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
Youdim MB
J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
[TBL] [Abstract][Full Text] [Related]
9. The effects of drugs inhibiting catecholamine uptake on tyramine and noradrenaline-induced contractions of the isolated rat vas deferens.
Barnett A; Symchowicz S; Taber RI
Br J Pharmacol; 1968 Nov; 34(3):484-92. PubMed ID: 5726781
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the blocking effect of alpha-adrenoceptor antagonist drugs towards directly and indirectly acting agonists on the rat vas deferens.
Lucchelli A; Santagostino-Barbone MG; D'Agostino G; Grana E
Pharmacol Res Commun; 1983 Mar; 15(3):267-80. PubMed ID: 6134294
[TBL] [Abstract][Full Text] [Related]
11. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
Hovevey-Sion D; Finberg JP
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
Youdim MB; Weinstock M
Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S; Nahrstedt H; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase B inhibition and the "cheese effect".
Youdim MB; Finberg JP
J Neural Transm Suppl; 1987; 25():27-33. PubMed ID: 3480939
[TBL] [Abstract][Full Text] [Related]
16. Influence of thyroid status on responses of rat isolated pulmonary artery, vas deferens and trachea to smooth muscle relaxant drugs.
O'Donnell SR; Wanstall JC; Mustafa MB
Br J Pharmacol; 1987 Sep; 92(1):221-9. PubMed ID: 3664088
[TBL] [Abstract][Full Text] [Related]
17. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
Laporte J; Jané F; Valdecasas FG
J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
[No Abstract] [Full Text] [Related]
18. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
Benedetti MS; Boucher T; Carlsson A; Fowler CJ
Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
[TBL] [Abstract][Full Text] [Related]
19. The effect of various MAO-B inhibitors on rabbit arterial strip response to tyramine.
Abdorubo A; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):673-83. PubMed ID: 3269534
[TBL] [Abstract][Full Text] [Related]
20. limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
Gal S; Abassi ZA; Youdim MB
Neurotox Res; 2010 Aug; 18(2):143-50. PubMed ID: 19894083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
